{"DataElement":{"publicId":"3563206","version":"1","preferredName":"Treatment Study Group Best Overall Response Type","preferredDefinition":"Text code for the best summary response evaluation result for a patient per treatment group.","longName":"TX_GP_BEST_RESP_CD","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3563205","version":"1","preferredName":"Treatment Study Group Best Overall Response","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Any number of entities (members) considered as a unit._Having the most positive qualities._Including everything._The pathologic and/or clinical changes that result from treatment.","longName":"END_TX_GP_BEST_RESP","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3563202","version":"1","preferredName":"Treatment Study Group","preferredDefinition":"A type of study protocol designed to evaluate intervention(s) for disease treatment.:Any number of entities (members) considered as a unit.","longName":"C49656:C43359","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Treatment Study","conceptCode":"C49656","definition":"A type of study protocol designed to evaluate intervention(s) for disease treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Group","conceptCode":"C43359","definition":"Any number of entities (members) considered as a unit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C77C7F57-A14D-ECBE-E040-BB89AD430B9B","latestVersionIndicator":"Yes","beginDate":"2012-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-17","modifiedBy":"ONEDATA","dateModified":"2012-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3563203","version":"1","preferredName":"Best Overall Response","preferredDefinition":"Having the most positive qualities.:Including everything.:The pathologic and/or clinical changes that result from treatment. The changes may refer to eradication of detectable disease, stabilization of disease, or disease progression.","longName":"C25432:C25605:C50995","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Best","conceptCode":"C25432","definition":"Having the most positive qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C77C7F57-A15F-ECBE-E040-BB89AD430B9B","latestVersionIndicator":"Yes","beginDate":"2012-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-17","modifiedBy":"ONEDATA","dateModified":"2012-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C77C7F57-A170-ECBE-E040-BB89AD430B9B","latestVersionIndicator":"Yes","beginDate":"2012-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182092","version":"4","preferredName":"Response Assessment Type","preferredDefinition":"Type of response to protocol intervention.","longName":"RESPS_ASSMNT_TP","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"16","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"DU","valueDescription":"Disease Unchanged","ValueMeaning":{"publicId":"2567163","version":"1","preferredName":"Disease Unchanged","longName":"2567163","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: The act of alteration or modification; changed or altered in form or character.: The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D368-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-04","modifiedBy":"COOPERM","dateModified":"2017-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-6359-35A0-E040-BB89AD434092","beginDate":"2003-11-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"CR","valueDescription":"Complete Response","ValueMeaning":{"publicId":"2570187","version":"1","preferredName":"Complete Response","longName":"2570187","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF38-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"KUMMEROA","dateModified":"2023-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-6363-35A0-E040-BB89AD434092","beginDate":"2002-07-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"MR","valueDescription":"Minimal/Marginal response","ValueMeaning":{"publicId":"2570401","version":"1","preferredName":"Minimal/Marginal response","longName":"2570401","preferredDefinition":"The smallest possible quantity.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Of questionable or minimal quality; just barely adequate or within a lower limit.: The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimum","conceptCode":"C25570","definition":"The smallest possible quantity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Marginal","conceptCode":"C67037","definition":"Of questionable or minimal quality; just barely adequate or within a lower limit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E00E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"COOPERM","dateModified":"2021-04-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-636D-35A0-E040-BB89AD434092","beginDate":"2002-07-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"NA","valueDescription":"NOT ASSESSED","ValueMeaning":{"publicId":"2559594","version":"1","preferredName":"NOT ASSESSED","longName":"2559594","preferredDefinition":"Indicates that an assessment was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Assessed","conceptCode":"C139527","definition":"Indicates that an assessment was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5D7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-6377-35A0-E040-BB89AD434092","beginDate":"2002-07-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"NE","valueDescription":"Not Evaluable","ValueMeaning":{"publicId":"2561822","version":"1","preferredName":"Not Evaluable","longName":"2561822","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BE8B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"REEVESD","dateModified":"2013-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-6381-35A0-E040-BB89AD434092","beginDate":"2002-07-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"NP","valueDescription":"NOT APPLICABLE PER PROTOCOL","ValueMeaning":{"publicId":"2561823","version":"1","preferredName":"NOT APPLICABLE PER PROTOCOL","longName":"2561823","preferredDefinition":"Determination of a value is not relevant in the current context.: For each, generally denoting a ratio.: A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the trial, but these could be represented in other protocol referenced documents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Per","conceptCode":"C65039","definition":"For each, generally denoting a ratio.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BE8C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"TSESU","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-638B-35A0-E040-BB89AD434092","beginDate":"2002-07-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"NR","valueDescription":"No Response","ValueMeaning":{"publicId":"2559542","version":"1","preferredName":"No Response","longName":"2559542","preferredDefinition":"No apparent change or worsening in lesion staging classification.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Response","conceptCode":"C123600","definition":"No apparent change or worsening in lesion staging classification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5A3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2021-04-28","changeDescription":"Added concept annotation and changed case of Long Name. mc 4/11/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-6395-35A0-E040-BB89AD434092","beginDate":"2004-03-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"PD","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"2559908","version":"1","preferredName":"Progressive Disease","longName":"2559908","preferredDefinition":"Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B711-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"HARTLEYG","dateModified":"2014-10-10","changeDescription":"Manually Curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-639F-35A0-E040-BB89AD434092","beginDate":"2002-07-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"PR","valueDescription":"Partial Response","ValueMeaning":{"publicId":"2559721","version":"1","preferredName":"Partial Response","longName":"2559721","preferredDefinition":"A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Response","conceptCode":"C18212","definition":"A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B656-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-63A9-35A0-E040-BB89AD434092","beginDate":"2002-07-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"SD","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"2560100","version":"1","preferredName":"Stable Disease","longName":"2560100","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeDescription":"Manually curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-63B3-35A0-E040-BB89AD434092","beginDate":"2002-07-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"TE","valueDescription":"Too early","ValueMeaning":{"publicId":"2567133","version":"1","preferredName":"Too early","longName":"2567133","preferredDefinition":"At a point before the usual, expected, or specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Too Early","conceptCode":"C133441","definition":"At a point before the usual, expected, or specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D34A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-22","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-22","modifiedBy":"COOPERM","dateModified":"2017-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-63BD-35A0-E040-BB89AD434092","beginDate":"2003-11-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"CRU","valueDescription":"Complete Response Unconfirmed","ValueMeaning":{"publicId":"2568774","version":"1","preferredName":"Complete Response Unconfirmed","longName":"2568774","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Having been established or verified.: The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9B3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-24","modifiedBy":"COOPERM","dateModified":"2017-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-63C7-35A0-E040-BB89AD434092","beginDate":"2004-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"UK","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-63D1-35A0-E040-BB89AD434092","beginDate":"2002-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"MX","valueDescription":"Mixed response","ValueMeaning":{"publicId":"2738405","version":"1","preferredName":"Mixed response","longName":"2738405","preferredDefinition":"Involving or composed of different kinds.: The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49BC9518-CC95-1A72-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-63DB-35A0-E040-BB89AD434092","beginDate":"2008-05-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"Non-CR/Non-PD","valueDescription":"Non-CR/Non-PD","ValueMeaning":{"publicId":"3084975","version":"1","preferredName":"Non-CR/Non-PD","longName":"3084975","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: The disappearance of all signs of cancer in response to treatment.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A disease process that is increasing in scope or severity.: The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"865F43A6-3FD6-75C4-E040-BB89AD4305AE","latestVersionIndicator":"Yes","beginDate":"2010-05-12","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9544757B-63F5-35A0-E040-BB89AD434092","beginDate":"2010-11-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"ONEDATA","dateModified":"2010-11-17","deletedIndicator":"No"},{"value":"RD","valueDescription":"Responsive Disease","ValueMeaning":{"publicId":"3241017","version":"1","preferredName":"Responsive Disease","longName":"3241017","preferredDefinition":"A disease response based on a reductin of 20% or more in the sum of the volume of all index lesions for four weeks or more.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A441BC76-0E31-1DF2-E040-BB89AD43505F","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A441BC76-0E4A-1DF2-E040-BB89AD43505F","beginDate":"2011-05-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-27","modifiedBy":"ONEDATA","dateModified":"2011-05-27","deletedIndicator":"No"},{"value":"PA","valueDescription":"Palliative Therapy","ValueMeaning":{"publicId":"2567166","version":"1","preferredName":"Palliative Therapy","longName":"2567166","preferredDefinition":"Palliative care is the patient-and family-centered active holistic care of patients with advanced, progressive disease. Traditional models reflect abandonment of proactive treatment and a simultaneous increase in symptom control and comfort-related services, as a disease progressed in linear fashion through its course. Essential components of palliative care are: pain and symptom control, communication regarding treatment and alternatives, prognosis, and available services, rehabilitation services, care that addresses treatment and palliative concerns, intellectual, emotional, social, and spiritual needs, terminal care, support in bereavement. The goal of palliative care is an achievement of the best quality of life for patients and their families.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Palliative Therapy","conceptCode":"C15292","definition":"The patient- and family-centered active holistic care of patients with advanced, progressive disease. Essential components of palliative care are: pain and symptom control, communication regarding treatment and alternatives, prognosis, and available services, rehabilitation services, care that addresses treatment and palliative concerns, intellectual, emotional, social, and spiritual needs, terminal care, support in bereavement. The goal of palliative care is an achievement of the best quality of life for patients and their families.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-05","modifiedBy":"REEVESD","dateModified":"2010-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B655744C-63E3-6963-E040-BB89AD433CD0","beginDate":"2012-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-01-12","modifiedBy":"ONEDATA","dateModified":"2012-01-12","deletedIndicator":"No"},{"value":"AJ","valueDescription":"Adjuvant Therapy","ValueMeaning":{"publicId":"3027773","version":"1","preferredName":"Adjuvant Therapy","longName":"3027773","preferredDefinition":"(AD-joo-vant) Treatment given after the primary treatment to increase the chances of a cure. Adjuvant therapy may include chemotherapy, radiation therapy, hormone therapy, or biological therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adjuvant Therapy","conceptCode":"C15675","definition":"Any therapy that is administered to augment or stimulate other treatment modalities or to minimize or prevent disease recurrence subsequent to the main treatment plan.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81FEA524-62BD-3572-E040-BB89AD431BC6","latestVersionIndicator":"Yes","beginDate":"2010-03-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B655744C-63F7-6963-E040-BB89AD433CD0","beginDate":"2012-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-01-12","modifiedBy":"ONEDATA","dateModified":"2012-01-12","deletedIndicator":"No"},{"value":"RP","valueDescription":"Response","ValueMeaning":{"publicId":"3303183","version":"1","preferredName":"Response","longName":"3303183","preferredDefinition":"The pathologic and/or clinical changes that result from treatment. The changes may refer to eradication of detectable disease, stabilization of disease, or disease progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B17ABAA3-8F9A-3C1C-E040-BB89AD435F48","latestVersionIndicator":"Yes","beginDate":"2011-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-11-11","modifiedBy":"ONEDATA","dateModified":"2011-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B655744C-640C-6963-E040-BB89AD433CD0","beginDate":"2012-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-01-12","modifiedBy":"ONEDATA","dateModified":"2012-01-12","deletedIndicator":"No"},{"value":"PPD","valueDescription":"Pseudoprogression","ValueMeaning":{"publicId":"3294017","version":"1","preferredName":"Pseudoprogression","longName":"3294017","preferredDefinition":"A radiologic finding observed during magnetic resonance imaging of brain glioblastoma, following concurrent radiotherapy and temozolomide treatment or vaccine therapy. It refers to the false positive finding of progression and enhancement of the lesion. It is considered a treatment effect due to tumor cell necrosis and subsequent edema formation and increased vascular permeability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pseudoprogression","conceptCode":"C98298","definition":"A radiologic finding observed during magnetic resonance imaging of brain glioblastoma, following concurrent radiotherapy and temozolomide treatment or vaccine therapy. It refers to the false positive finding of progression and enhancement of the lesion. It is considered a treatment effect due to tumor cell necrosis and subsequent edema formation and increased vascular permeability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF34AFA7-30AC-6D2E-E040-BB89AD4364C0","latestVersionIndicator":"Yes","beginDate":"2011-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-13","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":"Added concept annotation. mc 4/11/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CBA0DF0C-5AF1-36B7-E040-BB89AD435A4F","beginDate":"2012-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-09","modifiedBy":"ONEDATA","dateModified":"2012-10-09","deletedIndicator":"No"},{"value":"RPD","valueDescription":"Radiographic Progressive Disease","ValueMeaning":{"publicId":"3137642","version":"1","preferredName":"Radiographic Progressive Disease","longName":"3137642","preferredDefinition":"A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.: Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-Ray Imaging","conceptCode":"C38101","definition":"A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"902E0CEA-CB8F-FD71-E040-BB89AD437F44","latestVersionIndicator":"Yes","beginDate":"2010-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CBA0DF0C-5B06-36B7-E040-BB89AD435A4F","beginDate":"2012-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-09","modifiedBy":"ONEDATA","dateModified":"2012-10-09","deletedIndicator":"No"},{"value":"SPD","valueDescription":"Surgical progression","ValueMeaning":{"publicId":"3607737","version":"1","preferredName":"Surgical progression","longName":"3607737","preferredDefinition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBA0DF0C-5B14-36B7-E040-BB89AD435A4F","latestVersionIndicator":"Yes","beginDate":"2012-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CBA0DF0C-5B2D-36B7-E040-BB89AD435A4F","beginDate":"2012-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-09","modifiedBy":"ONEDATA","dateModified":"2012-10-09","deletedIndicator":"No"},{"value":"CPD","valueDescription":"Clinical Progression","ValueMeaning":{"publicId":"3607738","version":"1","preferredName":"Clinical Progression","longName":"3607738","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity.: Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBA0DF0C-5B37-36B7-E040-BB89AD435A4F","latestVersionIndicator":"Yes","beginDate":"2012-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CBA0DF0C-5B50-36B7-E040-BB89AD435A4F","beginDate":"2012-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-09","modifiedBy":"ONEDATA","dateModified":"2012-10-09","deletedIndicator":"No"},{"value":"NPB","valueDescription":"No Palliative Benefit","ValueMeaning":{"publicId":"3447889","version":"1","preferredName":"No Palliative Benefit","longName":"3447889","preferredDefinition":"The non-affirmative response to a question.: Benefits; the positive effects of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Benefit","conceptCode":"C25387","definition":"The positive effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF14486A-DD24-95BC-E040-BB89AD4305C8","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF14486A-DD3D-95BC-E040-BB89AD4305C8","beginDate":"2012-05-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-02","modifiedBy":"ONEDATA","dateModified":"2012-05-02","deletedIndicator":"No"},{"value":"PB","valueDescription":"Palliative Benefit","ValueMeaning":{"publicId":"3447890","version":"1","preferredName":"Palliative Benefit","longName":"3447890","preferredDefinition":"Benefits; the positive effects of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benefit","conceptCode":"C25387","definition":"The positive effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF14486A-DD47-95BC-E040-BB89AD4305C8","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF14486A-DD60-95BC-E040-BB89AD4305C8","beginDate":"2012-05-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-02","modifiedBy":"ONEDATA","dateModified":"2012-05-02","deletedIndicator":"No"},{"value":"IMR","valueDescription":"Immunoresponse","ValueMeaning":{"publicId":"5608376","version":"1","preferredName":"Immunoresponse","longName":"5608376","preferredDefinition":"A marked decrease in contrast enhancement that is not due to actual tumor shrinkage, but that may be due to immunotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoresponse","conceptCode":"C131144","definition":"A marked decrease in contrast enhancement that is not due to actual tumor shrinkage, but that may be due to immunotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"441B5856-0970-6675-E053-F662850A5A59","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"441B5856-0989-6675-E053-F662850A5A59","beginDate":"2016-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-20","modifiedBy":"ONEDATA","dateModified":"2016-12-20","deletedIndicator":"No"},{"value":"IPD","valueDescription":"Immunoprogression","ValueMeaning":{"publicId":"5608377","version":"1","preferredName":"Immunoprogression","longName":"5608377","preferredDefinition":"A marked increase in contrast enhancement that is not due to actual tumor growth, but that may be due to a reaction to immunotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoprogression","conceptCode":"C131143","definition":"A marked increase in contrast enhancement that is not due to actual tumor growth, but that may be due to a reaction to immunotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"441B5856-0995-6675-E053-F662850A5A59","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"441B5856-09AE-6675-E053-F662850A5A59","beginDate":"2016-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-20","modifiedBy":"ONEDATA","dateModified":"2016-12-20","deletedIndicator":"No"},{"value":"PSR","valueDescription":"Pseudoresponse","ValueMeaning":{"publicId":"5608378","version":"1","preferredName":"Pseudoresponse","longName":"5608378","preferredDefinition":"A marked decrease in contrast enhancement that is not due to actual tumor shrinkage, but that may be due to anti-angiogenic therapy or an increase in steroid dosage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pseudoresponse","conceptCode":"C131142","definition":"A marked decrease in contrast enhancement that is not due to actual tumor shrinkage, but that may be due to anti-angiogenic therapy or an increase in steroid dosage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"441B5856-09BA-6675-E053-F662850A5A59","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-20","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"441B5856-09D3-6675-E053-F662850A5A59","beginDate":"2016-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-20","modifiedBy":"ONEDATA","dateModified":"2016-12-20","deletedIndicator":"No"},{"value":"MD","valueDescription":"Minimal Residual Disease - Negative","ValueMeaning":{"publicId":"6004464","version":"1","preferredName":"Minimal Residual Disease - Negative","longName":"6004464","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.: Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BAECF5A-AA93-7952-E053-F662850A52A5","latestVersionIndicator":"Yes","beginDate":"2017-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BAECF5A-AAAC-7952-E053-F662850A52A5","beginDate":"2017-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-16","modifiedBy":"ONEDATA","dateModified":"2017-10-16","deletedIndicator":"No"},{"value":"VG","valueDescription":"Very good Partial Response","ValueMeaning":{"publicId":"3669391","version":"1","preferredName":"Very good Partial Response","longName":"3669391","preferredDefinition":"Partial response with additional serum and urine M-protein reduction, but not meeting complete response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Very Good Partial Response","conceptCode":"C123618","definition":"Partial response with additional serum and urine M-protein reduction, but not meeting complete response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4813252-CCB5-71BE-E040-BB89AD4341ED","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Added concept annotation. mc 4/11/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B5FB1DD-571F-40C6-E053-F662850ACFB7","beginDate":"2017-10-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-12","modifiedBy":"ONEDATA","dateModified":"2017-10-12","deletedIndicator":"No"},{"value":"SR","valueDescription":"Stringent Complete Response","ValueMeaning":{"publicId":"2955995","version":"1","preferredName":"Stringent Complete Response","longName":"2955995","preferredDefinition":"The confirmed disappearance of all signs of cancer, and absence of molecular or cytogenetic marker of disease, in response to treatment with additional biochemical, immunological and histopathological analyses to verify the CR.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stringent Complete Response","conceptCode":"C123614","definition":"The confirmed disappearance of all signs of cancer, and absence of molecular or cytogenetic marker of disease, in response to treatment with additional biochemical, immunological and histopathological analyses to verify the CR.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76D78551-E906-AA5D-E040-BB89AD435A4F","latestVersionIndicator":"Yes","beginDate":"2009-10-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2009-10-26","modifiedBy":"MAESKEB","dateModified":"2020-08-12","changeDescription":"Added concept annotation and changed case of Long Name. mc 4/11/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B5FB1DD-5733-40C6-E053-F662850ACFB7","beginDate":"2017-10-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-12","modifiedBy":"ONEDATA","dateModified":"2017-10-12","deletedIndicator":"No"},{"value":"PDP","valueDescription":"Progressive Disease, Preliminary","ValueMeaning":{"publicId":"6230045","version":"1","preferredName":"Progressive Disease, Preliminary","longName":"6230045","preferredDefinition":"Preceding all others in time or space or degree.: A disease process that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A9DF3D9-EAAB-4A5A-E053-F662850AC4D9","latestVersionIndicator":"Yes","beginDate":"2018-04-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-24","modifiedBy":"HARTLEYG","dateModified":"2018-04-24","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A9DF3D9-EAC4-4A5A-E053-F662850AC4D9","beginDate":"2018-04-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-24","modifiedBy":"ONEDATA","dateModified":"2018-04-24","deletedIndicator":"No"},{"value":"PDC","valueDescription":"Progressive Disease, Confirmed","ValueMeaning":{"publicId":"5895898","version":"1","preferredName":"Progressive Disease, Confirmed","longName":"5895898","preferredDefinition":"Having been established or verified.: A disease process that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53BAF5DA-7116-75C8-E053-F662850AED93","latestVersionIndicator":"Yes","beginDate":"2017-07-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-07","modifiedBy":"HARTLEYG","dateModified":"2018-04-24","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A9DF3D9-EAD8-4A5A-E053-F662850AC4D9","beginDate":"2018-04-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-24","modifiedBy":"ONEDATA","dateModified":"2018-04-24","deletedIndicator":"No"},{"value":"PPDC","valueDescription":"Pseudoprogression, Confirmed","ValueMeaning":{"publicId":"6230046","version":"1","preferredName":"Pseudoprogression, Confirmed","longName":"6230046","preferredDefinition":"Having been established or verified.: A radiologic finding observed during magnetic resonance imaging of brain glioblastoma, following concurrent radiotherapy and temozolomide treatment or vaccine therapy. It refers to the false positive finding of progression and enhancement of the lesion. It is considered a treatment effect due to tumor cell necrosis and subsequent edema formation and increased vascular permeability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pseudoprogression","conceptCode":"C98298","definition":"A radiologic finding observed during magnetic resonance imaging of brain glioblastoma, following concurrent radiotherapy and temozolomide treatment or vaccine therapy. It refers to the false positive finding of progression and enhancement of the lesion. It is considered a treatment effect due to tumor cell necrosis and subsequent edema formation and increased vascular permeability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A9DF3D9-EAE5-4A5A-E053-F662850AC4D9","latestVersionIndicator":"Yes","beginDate":"2018-04-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-24","modifiedBy":"HARTLEYG","dateModified":"2018-04-24","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A9DF3D9-EAFE-4A5A-E053-F662850AC4D9","beginDate":"2018-04-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-24","modifiedBy":"ONEDATA","dateModified":"2018-04-24","deletedIndicator":"No"},{"value":"PRP","valueDescription":"Partial Response, Preliminary","ValueMeaning":{"publicId":"2688949","version":"1","preferredName":"Partial Response, Preliminary","longName":"2688949","preferredDefinition":"Preceding all others in time or space or degree.: A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4BE624-D345-0D2B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A9DF3D9-EB12-4A5A-E053-F662850AC4D9","beginDate":"2018-04-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-24","modifiedBy":"ONEDATA","dateModified":"2018-04-24","deletedIndicator":"No"},{"value":"PRC","valueDescription":"Partial Response, Confirmed","ValueMeaning":{"publicId":"6230047","version":"1","preferredName":"Partial Response, Confirmed","longName":"6230047","preferredDefinition":"Having been established or verified.: A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A9DF3D9-EB1F-4A5A-E053-F662850AC4D9","latestVersionIndicator":"Yes","beginDate":"2018-04-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-24","modifiedBy":"HARTLEYG","dateModified":"2018-04-24","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A9DF3D9-EB38-4A5A-E053-F662850AC4D9","beginDate":"2018-04-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-24","modifiedBy":"ONEDATA","dateModified":"2018-04-24","deletedIndicator":"No"},{"value":"CRP","valueDescription":"Complete Response, Preliminary","ValueMeaning":{"publicId":"2770751","version":"1","preferredName":"Complete Response, Preliminary","longName":"2770751","preferredDefinition":"Preceding all others in time or space or degree.: The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53E0F58A-823C-509B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-08-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A9DF3D9-EB4C-4A5A-E053-F662850AC4D9","beginDate":"2018-04-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-24","modifiedBy":"ONEDATA","dateModified":"2018-04-24","deletedIndicator":"No"},{"value":"CRC","valueDescription":"Complete Response, Confirmed","ValueMeaning":{"publicId":"2677065","version":"1","preferredName":"Complete Response, Confirmed","longName":"2677065","preferredDefinition":"Having been established or verified.: The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39644D6E-B5DD-21D7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-05","modifiedBy":"HARTLEYG","dateModified":"2018-04-24","changeDescription":"User created long name for DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A9DF3D9-EB61-4A5A-E053-F662850AC4D9","beginDate":"2018-04-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-24","modifiedBy":"ONEDATA","dateModified":"2018-04-24","deletedIndicator":"No"},{"value":"IR","valueDescription":"Indeterminate Response","ValueMeaning":{"publicId":"6272413","version":"1","preferredName":"Indeterminate Response","longName":"6272413","preferredDefinition":"A response that is neither favorable nor unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate Response","conceptCode":"C123589","definition":"A response that is neither favorable nor unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BDB14F5-C3AF-40C4-E053-F662850AE75B","latestVersionIndicator":"Yes","beginDate":"2018-05-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-05-10","modifiedBy":"SOKKERL","dateModified":"2018-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FCA07AD-20F3-79B0-E053-F662850AC488","beginDate":"2018-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-29","modifiedBy":"ONEDATA","dateModified":"2018-06-29","deletedIndicator":"No"},{"value":"RL","valueDescription":"Recurrent Disease","ValueMeaning":{"publicId":"3828963","version":"1","preferredName":"Recurrent Disease","longName":"3828963","preferredDefinition":"The return of a disease after a period of remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2A8BB67-2BCE-B6D0-E040-BB89AD43093C","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"SOKKERL","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":"2023.1.20 Alt VM added per ticket request CADSR0001943. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C10DEE8D-6D11-4A70-E053-4EBD850A8782","beginDate":"2021-04-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-28","modifiedBy":"ONEDATA","dateModified":"2021-04-28","deletedIndicator":"No"},{"value":"TF","valueDescription":"Lack of Efficacy","ValueMeaning":{"publicId":"2578570","version":"1","preferredName":"Lack of Efficacy","longName":"2578570","preferredDefinition":"The lack of expected or desired effect related to a therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lack of Efficacy","conceptCode":"C48226","definition":"The lack of expected or desired effect related to a therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FFF7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-06","modifiedBy":"KUMMEROA","dateModified":"2023-03-22","changeDescription":null,"administrativeNotes":"2023.3.22 Alt VM added per ticket request CADSR0002191. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C10DEE8D-6D25-4A70-E053-4EBD850A8782","beginDate":"2021-04-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-28","modifiedBy":"ONEDATA","dateModified":"2021-04-28","deletedIndicator":"No"},{"value":"HI","valueDescription":"Hematologic Improvement","ValueMeaning":{"publicId":"3855533","version":"1","preferredName":"Hematologic Improvement","longName":"3855533","preferredDefinition":"Pertaining to or related to the blood and blood-forming organs.: A condition superior to an earlier condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematologic","conceptCode":"C62780","definition":"Pertaining to or related to the blood and blood-forming organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Improvement","conceptCode":"C94226","definition":"A condition superior to an earlier condition.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3F3DD72-55D7-9112-E040-BB89AD436F6A","latestVersionIndicator":"Yes","beginDate":"2013-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C10DEE8D-6D3A-4A70-E053-4EBD850A8782","beginDate":"2021-04-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-28","modifiedBy":"ONEDATA","dateModified":"2021-04-28","deletedIndicator":"No"},{"value":"CI","valueDescription":"Complete Response with Incomplete Bone Marrow Recovery","ValueMeaning":{"publicId":"6674540","version":"1","preferredName":"Complete Response with Incomplete Bone Marrow Recovery","longName":"6674540","preferredDefinition":"The disappearance of all signs of cancer in response to treatment accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Response with Incomplete Bone Marrow Recovery","conceptCode":"C103385","definition":"The disappearance of all signs of cancer in response to treatment accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83E8FF08-E035-1D09-E053-F662850ACD4A","latestVersionIndicator":"Yes","beginDate":"2019-03-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-12","modifiedBy":"MMADDINENI","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":"2023.3.22 Alt VM added per ticket request CADSR0002191. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C10DEE8D-6D4E-4A70-E053-4EBD850A8782","beginDate":"2021-04-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-28","modifiedBy":"ONEDATA","dateModified":"2021-04-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9544757B-6342-35A0-E040-BB89AD434092","latestVersionIndicator":"Yes","beginDate":"2004-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"COOPERM","dateModified":"2021-04-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"}],"ReferenceDocuments":[{"name":"Best overall response per Tre","type":"Preferred Question Text","description":"Best overall response per Treatment Group","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C77C7F57-A181-ECBE-E040-BB89AD430B9B","latestVersionIndicator":"Yes","beginDate":"2012-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-17","modifiedBy":"ZHANGWE","dateModified":"2013-09-16","changeDescription":"Curated to support Duke University Recursive Partitioning Assessment study","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}